Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice
Objective(s): Weight gain and metabolic disturbances such as dyslipidemia, are frequent side effects of second-generation antipsychotics, including olanzapine. This study examined the metabolic effects of chronic olanzapine exposure. In addition, we investigated the hepatic fatty acid effects of ola...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mashhad University of Medical Sciences
2018-05-01
|
| Series: | Iranian Journal of Basic Medical Sciences |
| Subjects: | |
| Online Access: | http://ijbms.mums.ac.ir/article_10615_6c547c4dfc213a36d7048873bc4843e0.pdf |
| _version_ | 1828491388196487168 |
|---|---|
| author | Po-Hsun Hou Geng-Ruei Chang Chin-Pin Chen Yen-Ling Lin I-Shuan Chao Ting-Ting Shen Frank Mao |
| author_facet | Po-Hsun Hou Geng-Ruei Chang Chin-Pin Chen Yen-Ling Lin I-Shuan Chao Ting-Ting Shen Frank Mao |
| author_sort | Po-Hsun Hou |
| collection | DOAJ |
| description | Objective(s): Weight gain and metabolic disturbances such as dyslipidemia, are frequent side effects of second-generation antipsychotics, including olanzapine. This study examined the metabolic effects of chronic olanzapine exposure. In addition, we investigated the hepatic fatty acid effects of olanzapine in female C57BL/6J mice fed a normal diet.Materials and Methods: Female C57BL/6J mice orally received olanzapine or normal saline for 7 weeks. The effects of long-term olanzapine exposure on body weight changes, food efficiency, blood glucose, triglyceride (TG), insulin, and leptin levels were observed. Hepatic TG and abdominal fat mass were investigated, and fat cell morphology was analyzed through histopathological methods. The levels of protein markers of fatty acid regulation in the liver, namely fatty acid synthase (FAS) and stearoyl-CoA desaturase-1 (SCD-1), were measured.Results: Olanzapine treatment increased the food intake of the mice as well as their body weight. Biochemical analyses showed that olanzapine increased blood TG, insulin, leptin, and hepatic TG. The olanzapine group exhibited increased abdominal fat mass and fat cell enlargement in abdominal fat tissue. Western blotting of the mouse liver revealed significantly higher (1.6-fold) levels of SCD-1 in the olanzapine group relative to the control group; by contrast, FAS levels in the two groups did not differ significantly.Conclusion: Enhanced lipogenesis triggered by increased hepatic SCD-1 activity might be a probable peripheral mechanism of olanzapine-induced dyslipidemia. Some adverse metabolic effects of olanzapine may be related to the disturbance of lipid homeostasis in the liver. |
| first_indexed | 2024-12-11T11:01:32Z |
| format | Article |
| id | doaj.art-49ed53d4510f4ce59d68bd4954704d20 |
| institution | Directory Open Access Journal |
| issn | 2008-3866 2008-3874 |
| language | English |
| last_indexed | 2024-12-11T11:01:32Z |
| publishDate | 2018-05-01 |
| publisher | Mashhad University of Medical Sciences |
| record_format | Article |
| series | Iranian Journal of Basic Medical Sciences |
| spelling | doaj.art-49ed53d4510f4ce59d68bd4954704d202022-12-22T01:09:52ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences2008-38662008-38742018-05-0121549550110.22038/ijbms.2018.22759.578010615Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J micePo-Hsun Hou0Geng-Ruei Chang1Chin-Pin Chen2Yen-Ling Lin3I-Shuan Chao4Ting-Ting Shen5Frank Mao6Department of Veterinary Medicine, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 40227, Taiwan|Department of Psychiatry, Taichung Veterans General Hospital, 1650 Taiwan Boulevard Section 4, Taichung 40705, Taiwan|Department of Social Work and Child Welfare, Providence University, 200, Sec. 7, Taiwan Boulevard, Taichung 43301, TaiwanDepartment of Veterinary Medicine, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 40227, Taiwan|Department of Veterinary Medicine, National Chiayi University, 580 Xinmin Road, Chiayi 60054, TaiwanDepartment of Veterinary Medicine, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 40227, TaiwanDepartment of Veterinary Medicine, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 40227, TaiwanDepartment of Veterinary Medicine, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 40227, TaiwanDepartment of Veterinary Medicine, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 40227, TaiwanDepartment of Veterinary Medicine, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 40227, TaiwanObjective(s): Weight gain and metabolic disturbances such as dyslipidemia, are frequent side effects of second-generation antipsychotics, including olanzapine. This study examined the metabolic effects of chronic olanzapine exposure. In addition, we investigated the hepatic fatty acid effects of olanzapine in female C57BL/6J mice fed a normal diet.Materials and Methods: Female C57BL/6J mice orally received olanzapine or normal saline for 7 weeks. The effects of long-term olanzapine exposure on body weight changes, food efficiency, blood glucose, triglyceride (TG), insulin, and leptin levels were observed. Hepatic TG and abdominal fat mass were investigated, and fat cell morphology was analyzed through histopathological methods. The levels of protein markers of fatty acid regulation in the liver, namely fatty acid synthase (FAS) and stearoyl-CoA desaturase-1 (SCD-1), were measured.Results: Olanzapine treatment increased the food intake of the mice as well as their body weight. Biochemical analyses showed that olanzapine increased blood TG, insulin, leptin, and hepatic TG. The olanzapine group exhibited increased abdominal fat mass and fat cell enlargement in abdominal fat tissue. Western blotting of the mouse liver revealed significantly higher (1.6-fold) levels of SCD-1 in the olanzapine group relative to the control group; by contrast, FAS levels in the two groups did not differ significantly.Conclusion: Enhanced lipogenesis triggered by increased hepatic SCD-1 activity might be a probable peripheral mechanism of olanzapine-induced dyslipidemia. Some adverse metabolic effects of olanzapine may be related to the disturbance of lipid homeostasis in the liver.http://ijbms.mums.ac.ir/article_10615_6c547c4dfc213a36d7048873bc4843e0.pdfAdiposityInsulinOlanzapineStearoyl-CoA desaturase-1- (SCD-1)Triglyceride |
| spellingShingle | Po-Hsun Hou Geng-Ruei Chang Chin-Pin Chen Yen-Ling Lin I-Shuan Chao Ting-Ting Shen Frank Mao Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice Iranian Journal of Basic Medical Sciences Adiposity Insulin Olanzapine Stearoyl-CoA desaturase-1- (SCD-1) Triglyceride |
| title | Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice |
| title_full | Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice |
| title_fullStr | Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice |
| title_full_unstemmed | Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice |
| title_short | Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice |
| title_sort | long term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female c57bl 6j mice |
| topic | Adiposity Insulin Olanzapine Stearoyl-CoA desaturase-1- (SCD-1) Triglyceride |
| url | http://ijbms.mums.ac.ir/article_10615_6c547c4dfc213a36d7048873bc4843e0.pdf |
| work_keys_str_mv | AT pohsunhou longtermadministrationofolanzapineinducesadiposityandincreaseshepaticfattyaciddesaturationproteininfemalec57bl6jmice AT gengrueichang longtermadministrationofolanzapineinducesadiposityandincreaseshepaticfattyaciddesaturationproteininfemalec57bl6jmice AT chinpinchen longtermadministrationofolanzapineinducesadiposityandincreaseshepaticfattyaciddesaturationproteininfemalec57bl6jmice AT yenlinglin longtermadministrationofolanzapineinducesadiposityandincreaseshepaticfattyaciddesaturationproteininfemalec57bl6jmice AT ishuanchao longtermadministrationofolanzapineinducesadiposityandincreaseshepaticfattyaciddesaturationproteininfemalec57bl6jmice AT tingtingshen longtermadministrationofolanzapineinducesadiposityandincreaseshepaticfattyaciddesaturationproteininfemalec57bl6jmice AT frankmao longtermadministrationofolanzapineinducesadiposityandincreaseshepaticfattyaciddesaturationproteininfemalec57bl6jmice |